2015
DOI: 10.21127/yaoyigc20150002
|View full text |Cite
|
Sign up to set email alerts
|

Chemical Constituents from the Barks of Swietenia macrophylla

Abstract: A new tirucallane-type triterpenoid, swietentol (1), was isolated from the barks of Swietenia macrophylla, together with four known triterpenoids (2-5), five known limonoids (6-10), and other six compounds (11-16). The structure of swietentol (1) was elucidated by extenstive 2D NMR and MS analysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…20 This data is in agreement with previous works showing the presence of phragmalin limonoids in species collected in Asia. [21][22][23][24] According to Moghadamtousi et al, 11 there seems not to be much variety in the class of compounds in S. macrophylla, since, among the 93 compounds listed in a phytochemical review, 77 of them belong to the limonoid class, among which 38 are phragmalin type.…”
Section: Introductionmentioning
confidence: 99%
“…20 This data is in agreement with previous works showing the presence of phragmalin limonoids in species collected in Asia. [21][22][23][24] According to Moghadamtousi et al, 11 there seems not to be much variety in the class of compounds in S. macrophylla, since, among the 93 compounds listed in a phytochemical review, 77 of them belong to the limonoid class, among which 38 are phragmalin type.…”
Section: Introductionmentioning
confidence: 99%
“…The drug discovery from natural products possess several advantages such as timeliness, faster and better methods for bioassay screening, and compound isolation. [30] Currently, naturally occurring phenols with antithrombotic activities have been reported in the recent literature or patents, which would provide many clues to find the novel agents. This progress holds a considerable promise to the development of alternative, highly effective and secure therapeutics agents and ultimately the eradication of thrombosis disease.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, substances that can accelerate its activation has promising applications for the treatment of thrombosis or arteriosclerosis [7]. Natural products with various structures offer more opportunities to discover lead compounds or drugs [8,9]. An isoindolone derivative, Fungi fibrinolytic compound (R)-2,5-bis((2R,3R)-2-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetr ahydropyrano [2,3-e]isoindol-8(2H)-yl)pentanoic acid (FGFC1, Fungi fibrinolytic compound 1, Figure 2), was isolated from a rare marine microorganism strain Stachybotrys longispora FG216.…”
Section: Introductionmentioning
confidence: 99%